Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | LTA4H | P09960 | 2/20 | 0.36 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7299873 | 0.96 | TSHR (0.40) | L3MBTL1TDP1LTA4HNR5A1TSHR | |
| SCHEMBL7003091 | 0.94 | NR5A1 (0.39) | L3MBTL1TDP1LTA4HNR5A1PLA2G4B | |
| SCHEMBL6999535 | 0.92 | NR5A1 (0.42) | L3MBTL1TDP1LTA4HNR5A1ALDH1A1 | |
| SCHEMBL6540133 | 0.92 | NR5A1 (0.42) | L3MBTL1TDP1LTA4HNR5A1ALDH1A1 | |
| SCHEMBL9688098 | 0.91 | MEN1 (0.41) | L3MBTL1TDP1LTA4HNR5A1TSHR | |
| SCHEMBL9687974 | 0.89 | MEN1 (0.44) | L3MBTL1TDP1NR5A1TSHRALDH1A1 | |
| SCHEMBL5958235 | 0.88 | TSHR (0.36) | L3MBTL1TDP1LTA4HTSHR | |
| SCHEMBL647523 | 0.85 | L3MBTL1 (0.49) | L3MBTL1TDP1LTA4HNR5A1TSHR | |
| SCHEMBL7296533 | 0.84 | NAAA (0.35) | L3MBTL1TSHR | |
| SCHEMBL7304240 | 0.82 | ALDH1A1 (0.44) | TSHRALDH1A1CYP3A4MAPK1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107846898-B | Diphenyl methanol derivatives for management of hypoxia inducible factor related disorders | 佐治亚州立大学研究基金会 | 2023-07-14 | — | — | CN | disclosed |
| CN-107846898-A | Diphenylcarbinol derivatives for the management of hypoxia inducible factor-related conditions | 佐治亚州立大学研究基金会 | 2018-03-27 | — | — | CN | disclosed |
| US-9112081-B2 | Sealing film for solar cell and solar cell obtained by use of the sealing film | BRIDGESTONE CORPORATION (JP) | 2015-08-18 | — | — | US | disclosed |
| CN-101960616-B | Sealing film for solar cell and solar cell using same | BRIDGESTONE CORP | 2013-12-18 | — | — | CN | disclosed |
| US-20110201649-A1 | AGRICULTURAL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-08-18 | — | — | US | disclosed |
| EP-2345328-A1 | COMPOSITION FOR AGRICULTURAL USE | Sumitomo Chemical Company, Limited (JP) | 2011-07-20 | — | — | EP | disclosed |
| CN-101960616-A | Sealing film for solar cell and solar cell using same | BRIDGESTONE CORP | 2011-01-26 | — | — | CN | disclosed |
| US-20110005592-A1 | SEALING FILM FOR SOLAR CELL AND SOLAR CELL OBTAINED BY USE OF THE SEALING FILM | BRIDGESTONE CORPORATION (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-2259331-A1 | SEALING FILM FOR SOLAR CELLS AND SOLAR CELL USING THE SAME | Bridgestone Corporation (JP) | 2010-12-08 | — | — | EP | disclosed |
| CN-101668767-A | Pyridine derivatives substituted with heterocyclic ring and phosphonoamino group and antifungal agent containing the same | EISAI R&D MAN CO LTD | 2010-03-10 | — | — | CN | disclosed |
| EP-0120463-B1 | ANTHRAQUINONE DYES AND LIQUID CRYSTAL COMPOSITIONS INCLUDING THE SAME | HITACHI, LTD. (JP) | 1991-11-06 | — | — | EP | disclosed |
| EP-0400519-A1 | 2-Hydroxy-n-propylamines, medicaments containing these compounds and method for preparing them | Dr. Karl Thomae GmbH (DE) | 1990-12-05 | — | — | EP | disclosed |
| EP-0072932-B1 | PIPERAZINONES, THEIR PREPARATION AND USE | CASSELLA Aktiengesellschaft (DE) | 1990-01-17 | — | — | EP | disclosed |
| EP-0098736-B1 | ANTHRAQUINONE DYES AND LIQUID CRYSTAL COMPOSITIONS CONTAINING THE DYES | MITSUBISHI KASEI CORPORATION (JP) | 1989-12-06 | — | — | EP | disclosed |
| US-4610804-A | Anthraquinone dyes and liquid crystal compositions including the same | HITACHI, LTD. (JP) | 1986-09-09 | — | — | US | disclosed |
| US-4598079-A | MEMORY DISORDERS | CASSELLA AKTIENGESELLSCHAFT (DE) | 1986-07-01 | — | — | US | disclosed |
| US-4507221-A | Anthraquinone dye and liquid crystal composition containing the same | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1985-03-26 | — | — | US | disclosed |
| EP-0120463-A2 | Anthraquinone dyes and liquid crystal compositions including the same | HITACHI, LTD. (JP) | 1984-10-03 | — | — | EP | disclosed |
| EP-0098736-A2 | Anthraquinone dyes and liquid crystal compositions containing the dyes | MITSUBISHI KASEI CORPORATION (JP) | 1984-01-18 | — | — | EP | disclosed |
| EP-0072932-A2 | Piperazinones, their preparation and use | CASSELLA Aktiengesellschaft (DE) | 1983-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201649-A1 | AGRICULTURAL COMPOSITION | H1-0, H1-3, H1-2 | L3MBTL1 779/4885TDP1 3862/4885LTA4H 3981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.